Publikationen von David Meierhofer

Meierhofer, D.; Weidner, C.; Sauer, S.: Integrative analysis of transcriptomics, proteomics and metabolomics data of white adipose and liver tissue of high-fat diet and rosiglitazone-treated insulin-resistant mice identified pathway alterations and molecular hubs. Journal of Proteome Research 13 (12), S. 5592 - 5602 (2014)

Luge, T.; Kube, M.; Freiwald, A.; Meierhofer, D.; Seemüller, E.; Sauer, S.: Transcriptomics assisted proteomic analysis of Nicotiana occidentalis infected by Candidatus Phytoplasma mali strain AT. Proteomics 14 (16), S. 1882 - 1889 (2014)

Cui, H.; Schlesinger, J.; Bansal, V.; Dunkel, I.; Meierhofer, D.; Rickert-Sperling, S.: 5Regulation of myogenesis via kinase driven activation of DPF3a, a BAF complex member and its interaction with transcription repressor HEY1. Cardiovascular Research 103 (Suppl 1), S 1 (2014)

Freiwald, A.; Weidner, C.; Witzke, A.; Huang, S.-Y.; Meierhofer, D.; Sauer, S.: Comprehensive proteomic data sets for studying adipocyte-macrophage cell-cell communication. Proteomics 13 (23-24), S. 3424 - 3428 (2013)

Meierhofer, D.; Weidner, C.; Hartmann, L.; Mayr, J. A.; Han, C.-T.; Schroeder, F. C.; Sauer, S.: Protein sets define disease states and predict in vivo effects of drug treatment. Molecular and Cellular Proteomics 12 (7), S. 1965 - 1979 (2013)

Weimann, M.; Grossmann, A.; Woodsmith, J.; Özkan, Z.; Birth, P.; Meierhofer, D.; Benlasfer, N.; Valovka, T.; Timmermann, B.; Wanker, E. E. et al.; Sauer, S.; Stelzl, U.: A Y2H-seq approach defines the human protein methyltransferase interactome. Nature methods 10 (4), S. 339 - 342 (2013)

Mayr, J. A.; Zimmermann, F. A.; Fauth, C.; Bergheim, C.; Meierhofer, D.; Radmayr, D.; Zschocke, J.; Koch, J.; Sperl, W.: Lipoic acid synthetase deficiency causes neonatal-onset epilepsy, defective mitochondrial energy metabolism, and glycine elevation. The American Journal of Human Genetics 89 (6), S. 792 - 797 (2011)

Meierhofer, D.; Wang, X.; Huang, L.; Kaiser, P.: Quantitative analysis of global ubiquitination in HeLa cells by mass spectrometry. Journal of Proteome Research 7 (10), S. 4566 - 4576 (2008)

Mayr, J. A.; Meierhofer, D.; Zimmermann, F.; Feichtinger, R.; Kögler, C.; Ratschek, M.; Schmeller, N.; Sperl, W.; Kofler, B.: Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clinical Cancer Research 14 (8), S. 2270 - 2275 (2008)

Mayr, J. A.; Zimmermann, F.; Meierhofer, D.; Schmeller, N.; Sperl, W.; Kofler, B.: Biochemical consequences of a pathogenic A3243G mtDNA mutation. Mitochondrion 6 (5), S. 268 - 269 (2006)

Wiesbauer, M.; Meierhofer, D.; Mayr, J. A.; Sperl, W.; Paulweber, B.; Kofler, B.: Multiplex primer extension analysis for rapid detection of major European mitochondrial haplogroups. Electrophoresis 27 (19), S. 3864 - 2868 (2006)

Meierhofer, D.; Ebner, S.; Mayr, J. A.; Jones, N. D.; Kofler, B.; Sperl, W.: Platelet transfusion can mimic somatic mtDNA mutations. Leukemia: the Journal of Normal and Malignant Hemopoiese ; Official Journal of the Leukemia Research Fund U.K. 20 (2), S. 362 - 363 (2006)

Meierhofer, D.; Mayr, J. A.; Fink, K.; Schmeller, N.; Kofler, B.; Sperl, W.: Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism. British Journal of Cancer 94 (2), S. 268 - 274 (2006)

Meierhofer, D.; Mayr, J. A.; Ebner, S.; Sperl, W.; Kofler, B.: Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations. Mitochondrion 5 (4), S. 282 - 296 (2005)

Meierhofer, D.; Mayr, J. A.; Foetschl, U.; Berger, A.; Fink, K.; Schmeller, N.; Hacker, G. W.; Hauser-Kronberger, C.; Kofler, B.; Sperl, W.: Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis 25 (6), S. 1005 - 1010 (2004)

Berger, A.; Mayr, J. A.; Meierhofer, D.; Fötschl, U.; Bittner, R.; Budka, H.; Grethen, C.; Huemer, M.; Kofler, B.; Sperl, W.: Severe depletion of mitochondrial DNA in spinal muscular atrophy. Acta Neuropathologica 105 (3), S. 245 - 251 (2003)

Meierhofer, D.; Kaiser, P.: Global Analysis of Ubiquitination. In: Neuroproteomics (Hg. Li, K. W.) (2011)

Kaiser, P.; Meierhofer, D.; Wang, X.; Huang, L.: Tandem affinity purification combined with mass spectrometry to identify components of protein complexes. In: Methods in molecular biology, Bd. 439, 2nd edition Aufl., S. 309 - 326 (Hg. Starkey, M.; Elaswarapu, R.). Humana Press (2008)

van der Weijden, V. A.; Stötzel, M.; Fauler, B.; Iyer, D.; Shahraz, M.; Meierhofer, D.; Rulands, S.; Alexandrov, T.; Mielke, T.; Bulut-Karslioglu, A.: Metabolic enhancement of mammalian developmental pausing. (2022)

Basu, S.; Martínez-Cristóbal, P.; Pesarrodona, M.; Frigolé-Vivas, M.; Szulc, E.; Lewis, M.; Bañuelos, C. A.; Sánchez-Zarzalejo, C.; Bielskutė, S.; Zhu, J. et al.; Garcia-Cabau, C.; Batlle, C.; Mateos, B.; Biesaga, M.; Escobedo, A.; Bardia, L.; Verdaguer, X.; Ruffoni, A.; Mawji, N. R.; Wang, J.; Tam, T.; Brun-Heath, I.; Ventura, S.; Meierhofer, D.; García, J.; Robustelli, P.; Stracker, T. H.; Sadar, M. D.; Riera, A.; Hnisz, D.; Salvatella, X.: Androgen receptor condensates as drug targets. (2022)